Fri. 10 May 2024, 4:55pm ET
Benzinga
Earnings, Earnings Misses, News
Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(2.46) per share which missed the analyst consensus estimate of $(1.77) by 38.98 percent. This is a 83.92 percent increase over losses of $(15.30) per share from the same period last year.